ABRILADA: payments to doctors
Payments that named ABRILADA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $45K
- Providers
- 103
- Transactions
- 166
- Average per transaction
- $271
The per-transaction average — $271 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 103 providers the average total is $437, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Pfizer | $33,235 | 73.8% |
| Whitehall International Inc | $11,810 | 26.2% |